INDICATIONS and USAGE:
PATADAY™ Solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
PATADAY™ Solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
IMPORTANT SAFETY INFORMATION:
Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least ten minutes after instilling PATADAY™ Solution before they insert their contact lenses. Safety and effectiveness in pediatric patients below the age of 3 have not been established.
Contraindications: PATADAY™ Solution is contraindicated in patients with a hypersensitivity to any components of this product.
Dosing and Administration: The recommended dose is one drop in each affected eye once a day.
Adverse Events: The most common adverse reactions to PATADAY™ Solution were cold syndrome and pharyngitis reported at an incidence of approximately 10%. Other adverse events included eye pain, blurred vision, sinusitis and headache occurring in 5% or less of the patients.
Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least ten minutes after instilling PATADAY™ Solution before they insert their contact lenses. Safety and effectiveness in pediatric patients below the age of 3 have not been established.
Contraindications: PATADAY™ Solution is contraindicated in patients with a hypersensitivity to any components of this product.
Dosing and Administration: The recommended dose is one drop in each affected eye once a day.
Adverse Events: The most common adverse reactions to PATADAY™ Solution were cold syndrome and pharyngitis reported at an incidence of approximately 10%. Other adverse events included eye pain, blurred vision, sinusitis and headache occurring in 5% or less of the patients.
| References: | |
| 1. | Vogelson CT, Abelson MB, Pasquine T, et al. Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration. Allergy Asthma Proc. 2004;25:69-75. |
| 2. | PATADAY™ Solution Package Insert. |
| 3. | Wolters Kluwer Health, Source® Pharmaceutical Audit Suite. August 2009-September 2010. |
|
©2010 Alcon Laboratories, Inc. 01/10 PAT10501WB |